Travere Therapeutics Inc (NASDAQ:TVTX) traded at $5.26 at close of the session on Friday, April 26, made a downward move of -2.41% on its previous day’s price.
Looking at the stock we see that its previous close was $5.39 . In terms of its 52-week price range, TVTX has a high of $22.75 and a low of $5.12. The company’s stock has lost about -31.42% over that past 30 days.
Travere Therapeutics Inc has a market cap of $400.29 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.97, with the EPS growth for the year raised at -$3.18 for 2024 and -$1.77 for next year. These figures represent -112.00% and 44.30% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $44.37 million, with a low of $38 million and a high of $60.85 million. The median projection represents growth adding up to -22.10% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $215.77 million, or 48.60% up from figures reported last year.
On the other hand, looking at the outlook for the TVTX stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -18.44% off its SMA20 and -28.56% from its 50-day simple moving average. The RSI (14) is pointing at 21.73 while the volatility over the past week is 6.14% and jumps to 5.71% over the past one month. The beta value is 0.69, while the average true range (ATR) is currently pointing at 0.38.
Coming back to Travere Therapeutics Inc (NASDAQ:TVTX), we note that the average 3-month trading volume was 1.21 million. Current shares outstanding are 75.37 million.
The insiders hold 1.41% of the company’s shares while institutions hold 113.78%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -41.49% down in year-to-date price movement.
